Basis: FMP quote price / unrounded diluted EPS from four consecutive issuer fiscal quarters. Source: stored company filings and market data; unavailable inputs remain N/A.
The P/E ratio is N/A as of 2026-10-06T18:01:50.284Z.
Calculation as of: 2026-10-06T18:01:50.284Z.
Quote observation: 2026-10-06T18:00:05.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: e78bbdb3a8988fdd9fdd63a4dcf124b38851ed281a9b1f93071349952e7e00d5
PE RATIO
N/A
| NAME | MARKET CAP | PE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| CVRx, Inc. (CVRX) | $44.45M | N/A | N/A | N/A | N/A |
| Rapid Micro Biosystems, Inc. (RPID)vs › | $44.40M | N/A | N/A | N/A | N/A |
| DarioHealth Corp. (DRIO)vs › | $43.88M | 8.70 | 6.98 | 6.98 | 6.98 |
| Werewolf Therapeutics, Inc. (HOWL)vs › | $45.20M | N/A | N/A | N/A | N/A |
| Nano-X Imaging Ltd. (NNOX)vs › | $43.51M | N/A | N/A | N/A | N/A |
| SANUWAVE Health Inc. (SNWV)vs › | $43.38M | 5.58 | 15.10 | 15.10 | 15.10 |
| BioStem Technologies, Inc. (BSEM)vs › | $43.22M | N/A | 7.83 | 14.59 | 14.59 |
| Precipio, Inc. (PRPO)vs › | $42.15M | N/A | N/A | N/A | N/A |
| Instil Bio, Inc. (TIL)vs › | $47.27M | N/A | N/A | N/A | N/A |
| Veru Inc. (VERU)vs › | $41.09M | N/A | 243.89 | 230.07 | 202.94 |
Trailing P/E
N/A
Forward P/E
N/A
Forward P/E is calculated using analyst consensus EPS estimates for the current or next fiscal year.
Calculation:
Current Price
$1.68
Forward EPS (Est.)
$-2.01
Forward P/E
N/A
Source: FMP Analyst Consensus Estimates. Forward EPS represents the average analyst estimate for the nearest fiscal year.
PE Ratio = Share Price / Diluted EPS (TTM)
The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute